Laurent Désiré

Title: Laurent Désiré: Innovator in Phosphodiesterase Inhibition

Introduction

Laurent Désiré is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target phosphodiesterase enzymes. His work has implications for treating various central nervous system diseases and metabolic disorders.

Latest Patents

Laurent Désiré holds a patent for "Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)." This invention relates to specific compounds that are effective in inhibiting PDE10A, which is crucial for treating conditions such as psychosis, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain, and ophthalmic diseases. He has 1 patent registered under his name.

Career Highlights

Throughout his career, Laurent has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Allergan, Inc. and Exonhit Therapeutics, S.A. His experience in these organizations has allowed him to contribute to innovative research and development in drug discovery.

Collaborations

Laurent has collaborated with several professionals in his field, including Bertrand Leblond and John E Donello. These partnerships have enhanced his research efforts and have led to advancements in the understanding of phosphodiesterase inhibitors.

Conclusion

Laurent Désiré is a distinguished inventor whose work in phosphodiesterase inhibition has the potential to impact the treatment of various diseases. His contributions to medicinal chemistry continue to pave the way for future innovations in healthcare.